Bruker Corporation to Acquire ELITech Group from PAI Partners

Agilent Technologies Acquires Biocare Medical

March 9, 2026

Medical Devices

Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, for $950 million in an all-cash transaction. The acquisition expands Agilent’s pathology portfolio—particularly in immunohistochemistry (IHC)—and is expected to be accretive to Agilent’s top-line growth rate, margin profile, and non-instrument revenue mix in Year 1.

Bruker Corporation Majority Investment in RECIPE Chemicals + Instruments GmbH

April 16, 2025

Medical Devices

Bruker Corporation announced a majority investment in RECIPE Chemicals + Instruments GmbH, a Munich-based provider of mass spectrometry‑based in vitro diagnostic assay kits for therapeutic drug monitoring. The deal (financial terms undisclosed) brings RECIPE's ClinMASS kits into Bruker's portfolio and creates a strategic collaboration to introduce high‑throughput, chromatography‑free ClinDART workflows on Bruker's EVOQ‑DART TQ⁺ platform.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

Adelis Equity Partners Acquires Majority Stake in Bruhn NewTech

June 28, 2024

Software

Adelis Equity Partners (via Adelis Equity Partners Fund III AB) has acquired a majority stake in Danish CBRN knowledge-management software provider Bruhn NewTech, with the deal closing on June 28. The investment is the first step in Adelis’ plan to build a European defense-focused technology group and will support Bruhn NewTech’s global growth and product development.

Bruker Corporation Acquires Spectral Instruments Imaging

February 6, 2024

Medical Devices

Bruker Corporation has acquired Spectral Instruments Imaging LLC, a Tucson-based maker of preclinical in‑vivo optical imaging systems, to broaden Bruker BioSpin's preclinical imaging portfolio. Financial terms were not disclosed; SII generated over $10 million in revenue in 2023 and will expand Bruker's capabilities in bioluminescence, fluorescence and X‑ray preclinical imaging.

Bruker Corporation Acquires Optimal Industrial Automation and Technologies

April 5, 2022

Pharmaceuticals

Bruker Corporation acquired UK-based Optimal Industrial Automation and Technologies, a provider of pharma and biopharma process analytical technology (PAT), manufacturing automation and QA software (including the synTQ platform). The acquisition strengthens Bruker's biopharma manufacturing automation and PAT software capabilities to complement its instrumentation portfolio and accelerate integrated solutions for pharmaceutical and biotech customers.